These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 20951783

  • 1. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
    Cırpanlı Y, Allard E, Passirani C, Bilensoy E, Lemaire L, Calış S, Benoit JP.
    Int J Pharm; 2011 Jan 17; 403(1-2):201-6. PubMed ID: 20951783
    [Abstract] [Full Text] [Related]

  • 2. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
    Cirpanli Y, Bilensoy E, Lale Doğan A, Caliş S.
    Eur J Pharm Biopharm; 2009 Sep 17; 73(1):82-9. PubMed ID: 19442723
    [Abstract] [Full Text] [Related]

  • 3. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC.
    J Control Release; 2008 May 08; 127(3):208-18. PubMed ID: 18336946
    [Abstract] [Full Text] [Related]

  • 4. Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel.
    Ozeki T, Kaneko D, Hashizawa K, Imai Y, Tagami T, Okada H.
    Int J Pharm; 2012 May 10; 427(2):299-304. PubMed ID: 22366485
    [Abstract] [Full Text] [Related]

  • 5. Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
    Callewaert M, Dukic S, Van Gulick L, Vittier M, Gafa V, Andry MC, Molinari M, Roullin VG.
    J Biomed Mater Res A; 2013 May 10; 101(5):1319-27. PubMed ID: 23065812
    [Abstract] [Full Text] [Related]

  • 6. Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma.
    Householder KT, DiPerna DM, Chung EP, Wohlleb GM, Dhruv HD, Berens ME, Sirianni RW.
    Int J Pharm; 2015 Feb 20; 479(2):374-80. PubMed ID: 25562639
    [Abstract] [Full Text] [Related]

  • 7. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y, Pan J, Feng SS.
    Int J Pharm; 2010 Aug 16; 395(1-2):243-50. PubMed ID: 20472049
    [Abstract] [Full Text] [Related]

  • 8. Development of polymeric and cyclodextrin nanoparticles for camptothecin delivery.
    Cirpanli Y, Bilensoy E, Dogan AL, Calis S.
    J Control Release; 2010 Nov 20; 148(1):e21-3. PubMed ID: 21529600
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V.
    J Control Release; 2009 Jan 05; 133(1):11-7. PubMed ID: 18950666
    [Abstract] [Full Text] [Related]

  • 13. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
    Xin H, Chen L, Gu J, Ren X, Wei Z, Luo J, Chen Y, Jiang X, Sha X, Fang X.
    Int J Pharm; 2010 Dec 15; 402(1-2):238-47. PubMed ID: 20934500
    [Abstract] [Full Text] [Related]

  • 14. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X, Zou W, Liu C, Zhang N, Fu C.
    Drug Dev Ind Pharm; 2009 Nov 15; 35(11):1375-83. PubMed ID: 19832638
    [Abstract] [Full Text] [Related]

  • 15. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.
    Martins S, Tho I, Reimold I, Fricker G, Souto E, Ferreira D, Brandl M.
    Int J Pharm; 2012 Dec 15; 439(1-2):49-62. PubMed ID: 23046667
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
    Bilensoy E, Gürkaynak O, Doğan AL, Hincal AA.
    Int J Pharm; 2008 Jan 22; 347(1-2):163-70. PubMed ID: 17689901
    [Abstract] [Full Text] [Related]

  • 17. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
    Martins SM, Sarmento B, Nunes C, Lúcio M, Reis S, Ferreira DC.
    Eur J Pharm Biopharm; 2013 Nov 22; 85(3 Pt A):488-502. PubMed ID: 23994244
    [Abstract] [Full Text] [Related]

  • 18. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M, Zhu S, Jiang Y, Tang G, Sun C, Fang C, Shi B, Pei Y.
    J Control Release; 2010 Jan 04; 141(1):22-9. PubMed ID: 19735683
    [Abstract] [Full Text] [Related]

  • 19. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
    Zhu Z, Li Y, Li X, Li R, Jia Z, Liu B, Guo W, Wu W, Jiang X.
    J Control Release; 2010 Mar 19; 142(3):438-46. PubMed ID: 19896997
    [Abstract] [Full Text] [Related]

  • 20. Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.
    Svenson S, Wolfgang M, Hwang J, Ryan J, Eliasof S.
    J Control Release; 2011 Jul 15; 153(1):49-55. PubMed ID: 21406204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.